3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
42
Gastrointestinal
40
Head & Neck
11
Thoracic
10
Gynecologic
9
Other hematologic neoplasm
8
Tumor-Agnostic
7
Genitourinary
6
Lymphoid
4
Endocrine
3
Sarcoma
2
CNS
2
Plasma cell
1
Other solid neoplasm
1
Other neoplasm
1
Other
1
NET
1
Dermatologic
1
Classical hematology
1
Conditions
Cervical Cancer Screening
1
Interventions
Cyclophosphamide
13
Peripheral Blood Stem Cell Transplantation
9
Biopsy
9
fludarabine phosphate
8
Busulfan
8
Whole-Body Irradiation
7
Surveys and Questionnaires
6
Mycophenolic Acid
6
Educational Status
6
Early Intervention, Educational
6
Carboplatin
6
fludarabine
5
Tacrolimus
5
Paclitaxel
5
Methotrexate
5
Methods
5
Melphalan
5
Epoetin Alfa
5
Decitabine
5
Cyclosporine
5
Colposcopy
5
Cisplatin
5
Celecoxib
5
Antilymphocyte Serum
5
Aminolevulinic Acid
5
Sulindac
4
Selenium
4
Radiotherapy
4
Patient Reported Outcome Measures
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Control Groups
×
Other neoplasm
×
Clear all
NCT06800664
2025-01-31
HOPE-inG
Baylor University
Phase NA
Not yet recruiting
1,500 enrolled